Salarius Pharmaceuticals (SLRX) Competitors $0.76 -0.03 (-4.29%) Closing price 07/9/2025 04:00 PM EasternExtended Trading$0.72 -0.04 (-5.44%) As of 08:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLRX vs. TCRT, SNPX, CHRO, TSBX, BMRA, TRAW, OBSV, CYCC, JBIO, and CLDIShould you be buying Salarius Pharmaceuticals stock or one of its competitors? The main competitors of Salarius Pharmaceuticals include Alaunos Therapeutics (TCRT), Synaptogenix (SNPX), Chromocell Therapeutics (CHRO), Turnstone Biologics (TSBX), Biomerica (BMRA), Traws Pharma (TRAW), ObsEva (OBSV), Cyclacel Pharmaceuticals (CYCC), Jade Biosciences (JBIO), and Calidi Biotherapeutics (CLDI). These companies are all part of the "pharmaceutical products" industry. Salarius Pharmaceuticals vs. Its Competitors Alaunos Therapeutics Synaptogenix Chromocell Therapeutics Turnstone Biologics Biomerica Traws Pharma ObsEva Cyclacel Pharmaceuticals Jade Biosciences Calidi Biotherapeutics Alaunos Therapeutics (NASDAQ:TCRT) and Salarius Pharmaceuticals (NASDAQ:SLRX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings. Does the media refer more to TCRT or SLRX? In the previous week, Salarius Pharmaceuticals had 3 more articles in the media than Alaunos Therapeutics. MarketBeat recorded 3 mentions for Salarius Pharmaceuticals and 0 mentions for Alaunos Therapeutics. Alaunos Therapeutics' average media sentiment score of 0.00 equaled Salarius Pharmaceuticals'average media sentiment score. Company Overall Sentiment Alaunos Therapeutics Neutral Salarius Pharmaceuticals Neutral Is TCRT or SLRX more profitable? Alaunos Therapeutics' return on equity of -169.34% beat Salarius Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Alaunos TherapeuticsN/A -169.34% -124.28% Salarius Pharmaceuticals N/A -324.13%-174.40% Which has more risk & volatility, TCRT or SLRX? Alaunos Therapeutics has a beta of -0.79, indicating that its stock price is 179% less volatile than the S&P 500. Comparatively, Salarius Pharmaceuticals has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500. Which has stronger valuation & earnings, TCRT or SLRX? Alaunos Therapeutics has higher revenue and earnings than Salarius Pharmaceuticals. Alaunos Therapeutics is trading at a lower price-to-earnings ratio than Salarius Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlaunos Therapeutics$10K821.64-$4.68M-$2.54-1.97Salarius PharmaceuticalsN/AN/A-$5.58M-$4.82-0.16 Do institutionals and insiders believe in TCRT or SLRX? 27.7% of Alaunos Therapeutics shares are held by institutional investors. Comparatively, 11.9% of Salarius Pharmaceuticals shares are held by institutional investors. 16.1% of Alaunos Therapeutics shares are held by company insiders. Comparatively, 1.2% of Salarius Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryAlaunos Therapeutics beats Salarius Pharmaceuticals on 7 of the 10 factors compared between the two stocks. Get Salarius Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SLRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLRX vs. The Competition Export to ExcelMetricSalarius PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.68M$2.39B$5.51B$8.95BDividend YieldN/A1.80%5.25%4.04%P/E Ratio-0.169.2627.9920.16Price / SalesN/A590.63411.53174.36Price / CashN/A161.3437.0657.97Price / Book0.804.638.145.62Net Income-$5.58M$31.26M$3.16B$248.50M7 Day Performance-15.04%5.50%3.14%4.49%1 Month Performance2.73%3.01%3.46%7.03%1 Year Performance-72.43%1.89%34.19%21.07% Salarius Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLRXSalarius Pharmaceuticals0.7107 of 5 stars$0.76-4.3%N/A-72.3%$1.68MN/A-0.1620News CoverageGap UpTCRTAlaunos Therapeutics0.4847 of 5 stars$4.85-5.5%N/A-21.4%$8.41M$10K-1.9140SNPXSynaptogenix1.1689 of 5 stars$7.85+29.8%$14.00+78.3%+82.2%$8.40MN/A-0.784High Trading VolumeCHROChromocell TherapeuticsN/A$1.26-6.7%N/A-87.9%$8.31MN/A-1.024Gap UpTSBXTurnstone Biologics1.5665 of 5 stars$0.36+1.8%$0.45+25.3%-84.0%$8.16M$19.31M-0.1382High Trading VolumeBMRABiomerica0.39 of 5 stars$3.16+0.3%N/A-1.6%$8.02M$5.41M-1.3660TRAWTraws Pharma0.1073 of 5 stars$1.48+3.5%N/AN/A$7.96M$230K-0.0517Gap UpOBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150CYCCCyclacel Pharmaceuticals0.7452 of 5 stars$0.33-0.2%N/A-99.0%$7.86M$40K-0.0114Stock SplitJBIOJade Biosciences2.1821 of 5 stars$9.99+8.7%$14.00+40.1%N/A$7.72MN/A0.0020Gap DownCLDICalidi Biotherapeutics0.4805 of 5 stars$0.23+2.8%N/A-53.5%$7.31M$50K0.0038News CoverageGap Up Related Companies and Tools Related Companies TCRT Competitors SNPX Competitors CHRO Competitors TSBX Competitors BMRA Competitors TRAW Competitors OBSV Competitors CYCC Competitors JBIO Competitors CLDI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLRX) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLRX Stock Alerts